Drug plant to specialize in halal compliance

Vivapharm, a startup producer of halal-certified pharmaceuticals, kicked off construction this week of a $26-million, 100,000-square-foot manufacturing plant in tiny Brunei, a sovereign state in Southeast Asia. Brunei already boasts the Halal Brand Project, an initiative to certify foods as halal, or lawful, for Muslim consumption. Vivapharm will extend the certification effort to drugs and nutraceuticals produced via GMP processes. It will focus on OTC and prescription drugs for Asia Pacific, the Middle East, Western Europe and the U.S. The company is funded by Canada's Viva Pharmaceutical and investors. Story | Article


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.